BACTIGEN GROUP B STREPTOCOCCUS-CS TEST
K-Number: K872114 · 1987-08-27
Advertisement
Device Summary
Frequently Asked Questions
What is the BACTIGEN GROUP B STREPTOCOCCUS-CS TEST?
BACTIGEN GROUP B STREPTOCOCCUS-CS TEST is a medical device that received FDA 510(k) clearance on 1987-08-27. The listed applicant is Armkel, LLC. The 510(k) number is K872114.
When did BACTIGEN GROUP B STREPTOCOCCUS-CS TEST receive FDA 510(k) clearance?
BACTIGEN GROUP B STREPTOCOCCUS-CS TEST received FDA 510(k) clearance on 1987-08-27, under 510(k) number K872114.
Who is the listed applicant for BACTIGEN GROUP B STREPTOCOCCUS-CS TEST?
The FDA 510(k) record lists Armkel, LLC as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for BACTIGEN GROUP B STREPTOCOCCUS-CS TEST?
The FDA product code for BACTIGEN GROUP B STREPTOCOCCUS-CS TEST is GTZ.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Armkel, LLC as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: GTZ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement